We are live on ! Find out more
CM

Caption Management Portfolio holdings

AUM $17.1B
1-Year Est. Return 70.99%
This Fund
S&P 500
This Quarter Est. Return
+22.77%
1 Year Est. Return
+70.99%
3 Year Est. Return
+176.06%
5 Year Est. Return
+263.89%
10 Year Est. Return
AUM
$7.42B
AUM Growth
+$927M
Cap. Flow
+$49.5M
Cap. Flow %
0.67%
Top 10 Hldgs %
14.12%
Holding
1,799
New
559
Increased
265
Reduced
280
Closed
507

Top Buys

Rank Stock Value
1
VZ icon
Verizon
VZ
+$90.4M
2
CYTK icon
Cytokinetics
CYTK
+$14.7M
3
CI icon
Cigna
CI
+$13.5M
4
MPC icon
Marathon Petroleum
MPC
+$9.87M
5
CHTR icon
Charter Communications
CHTR
+$9.58M

Top Sells

Rank Stock Value
1
LMT icon
Lockheed Martin
LMT
+$28.8M
2
IP icon
International Paper
IP
+$25.9M
3
BMY icon
Bristol-Myers Squibb
BMY
+$18.8M
4
AMT icon
American Tower
AMT
+$16.2M
5
ONON icon
On Holding
ONON
+$14.9M

Sector Composition

Rank Sector Weight
1 Healthcare 2.67%
2 Communication Services 2.38%
3 Financials 1.61%
4 Technology 1.29%
5 Consumer Discretionary 1.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WEN icon
1226
Wendy's
WEN
$1.4B
$42.9K ﹤0.01%
2,201
PDSB icon
1227
PDS Biotechnology
PDSB
$38.4M
$40.7K ﹤0.01%
+8,181
New +$40.7K
CLS icon
1228
Celestica
CLS
$38.1B
$39.1K ﹤0.01%
1,337
-322,791
-100% -$8.59M
BLNK icon
1229
Blink Charging
BLNK
$74.3M
$39K ﹤0.01%
+11,500
New +$35.9K
GNW icon
1230
CALL
Genworth Financial
GNW
$3.76B
$38.7K ﹤0.01%
5,800
ALLK
1231
DELISTED
Allakos
ALLK
$38.2K ﹤0.01%
+14,000
New +$31.5K
CUE icon
1232
Cue Biopharma
CUE
$113M
$37K ﹤0.01%
467
APYX icon
1233
CALL
Apyx Medical
APYX
$173M
$36.4K ﹤0.01%
13,900
EOLS icon
1234
CALL
Evolus
EOLS
$385M
$35.8K ﹤0.01%
3,400
-246,400
-99% -$2.2M
EVGO icon
1235
PUT
EVgo
EVGO
$223M
$35.8K ﹤0.01%
+10,000
New +$29.6K
NBIS
1236
Nebius Group N.V.
NBIS
$48.3B
$35.8K ﹤0.01%
1,888
PMVP icon
1237
PMV Pharmaceuticals
PMVP
$59.2M
$34.8K ﹤0.01%
+11,221
New +$29.7K
MVIS icon
1238
PUT
Microvision
MVIS
$6.21M
$33.3K ﹤0.01%
+12,500
New +$28.7K
DOCN icon
1239
DigitalOcean
DOCN
$13.7B
$31.8K ﹤0.01%
+866
New +$24K
PROCW
1240
DELISTED
Procaps Group, S.A. Warrants
PROCW
$31.2K ﹤0.01%
242,319
BBWI icon
1241
Bath & Body Works
BBWI
$4.06B
$30.7K ﹤0.01%
711
-46,859
-99% -$1.58M
CRNT icon
1242
Ceragon Networks
CRNT
$197M
$30.3K ﹤0.01%
14,038
-31,534
-69% -$57.9K
RGNX icon
1243
Regenxbio
RGNX
$620M
$30.2K ﹤0.01%
+1,682
New +$29.6K
ZIM icon
1244
ZIM Integrated Shipping Services
ZIM
$3.04B
$29.9K ﹤0.01%
+3,026
New +$25.4K
SRPT icon
1245
Sarepta Therapeutics
SRPT
$1.57B
$28.9K ﹤0.01%
+300
New +$28.8K
CUE icon
1246
CALL
Cue Biopharma
CUE
$113M
$28.2K ﹤0.01%
357
TXT icon
1247
Textron
TXT
$14.7B
$28.1K ﹤0.01%
+350
New +$27.1K
OLMA icon
1248
Olema Pharmaceuticals
OLMA
$1B
$28.1K ﹤0.01%
+2,000
New +$26.9K
VKTX icon
1249
Viking Therapeutics
VKTX
$3.7B
$28K ﹤0.01%
1,504
-10,416
-87% -$136K
UBER icon
1250
Uber
UBER
$143B
$26.3K ﹤0.01%
+427
New +$22.3K

Similar funds

Caption Management's Q4 2023 Portfolio in Review

As of Q4 2023, Caption Management held 1,799 positions worth $7.42B, up 14% from $6.49B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Caption Management's Q4 2023 filing shows 559 new, 265 increased, 280 reduced and 507 closed positions. Its largest new stake was Verizon: 2,556,000 shares worth $96.4M. The largest sale was Lockheed Martin, an estimated $28.8M.

By sector, the portfolio is most concentrated in Healthcare at 2.7% of assets, up from 2.4% a quarter earlier, followed by Communication Services and Financials.

  • Caption Management's largest Q4 2023 buy was Verizon: 2,556,000 shares worth $96.4M.
  • Caption Management added most to Cytokinetics in Q4 2023, an estimated $14.7M increase.
  • Caption Management's biggest Q4 2023 reduction was International Paper, cutting an estimated $25.9M.
  • Caption Management fully exited Lockheed Martin in Q4 2023, selling an estimated $28.8M.
  • Caption Management's ten largest holdings make up 14% of its $7.42B portfolio in Q4 2023.
  • Caption Management opened 559 new positions and closed 507 in Q4 2023.
  • Caption Management's portfolio value rose 14% quarter-over-quarter to $7.42B.

Based on Caption Management's 13F filing for Q4 2023, filed 14 Feb 2024.